Biocore Group

Internation Conference on Drug Research and Regulatory

July 08-09, 2019 | Kuala lumpur, Malaysia

About Conference

Biocore extend a warm welcome to the distinguished speakers, delegates, Pharma Analysts, Quality Assurance, clinical, medical professionals, researchers, and industry leaders from all around the world to attend the International Conference on Drug Research and Regulatory Affairs (Drug Research Congress) during March 18-20, 2019, Dubai, UAE

This event will focus on various important disciplines of Pharmaceutical Sciences, Quality Assurance, Regulatory Affairs, SOP’s, chemistry, microbiology, and chromatographic techniques. Drug Research Congress will have a variety of plenary lectures, session lectures and poster presentations, Scientific Exhibitions, Panel Discussions, and the B2B meetings with world renowned speakers, and leading specialists involved in clinical and medical sciences.

Drug Research Congress will provide an unparalleled prospect to get associated with leading pharma analysts, quality assurance, clinical, medical professionals, quality control clinicians and delegates from industries focusing on Drug Research and Regulatory Affairs etc. This International conference anticipating more than 300 presentations and eminent Keynote lectures from 50 different countries. The attending delegates from top most universities, renowned organizations, Societies and Editorial Board Members of Biocore Journals will make the conference a huge success.

We hope that you will find Drug Research Congress is enjoyable and valuable.

    Important Dates
  •    Early Bird : January 27, 2019
  •   Abstract Submission: March 26, 2018
  •    Regular Registration: March 24, 2019
  •    Spot Registration: July 08-09, 2019

Scientific Sessions

  • Phases of Drug Development
  • Drug Therapy
  • Drug Design
  • Novel Drug delivery systems
  • Bioavailability and Bioequivalence
  • Pharmacognosy
  • Micro-particle drug delivery
  • Therapeutic targets
  • Clinical Pharmacology
  • Pharmacokinetics
  • Nanoparticles for drug delivery
  • Biosimilars
  • Clinical Affairs and Regulatory Strategies
  • Global Regulatory Intelligence
  • Regulatory Challenges for Medical Devices
  • Best Industry Practices
  • Properties of Drugs